Summary
Updated Aug 31, 2026
Russell Kevin Klass is Sr Vice President, Sales of Zomedica Corp. (ZOMDF). 10 SEC Form 4 filings on record going back to 2024, most recently on 7 August 2026. Most recent open-market trade: bought $15K of ZOMDF on 14 November 2025. Lifetime open-market purchases: $147K. Historical track record: 5/5 stars across 9 tracked purchases.
Recent Transactions
9Every recent SEC Form 4 transaction Russell Kevin Klass has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 9 |
| Purchases with forward-return data | 7 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +3.81% |
| Avg 30-day return | +77.12% |
| Avg 90-day return | +80.45% |
| Best 30-day return | +179.54% |
Trading Pattern
InsiderAlpha's records for Russell Kevin Klass go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. The typical open-market purchase is $16K (9 buys totaling $147K). The largest single buy on record is $35K of ZOMDF in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Russell Kevin Klass. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Johnny D. Powers - $35K of ZOMDF open-market activity on record
- Anthony K. Blair - $23K of ZOMDF open-market activity on record
- Larry C. Heaton II - $12K of ZOMDF open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Russell Kevin Klass?
Russell Kevin Klass is a corporate insider, tracked as Sr Vice President, Sales of Zomedica Corp. (ZOMDF). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Russell Kevin Klass submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Russell Kevin Klass been buying or selling stock?
Recorded transactions: 9 open-market purchases ($147K) and 0 open-market sales across all tracked filings.
How accurate is Russell Kevin Klass's historical track record?
Across 9 tracked purchases, Russell Kevin Klass averaged +77.1% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Russell Kevin Klass's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Russell Kevin Klass and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial